Helix Biopharma (CC:HBP) Signs Agreement With Apotex Inc.  
10/19/2005 5:12:52 PM

AURORA, ONTARIO--(CCNMatthews - Feb. 28, 2005) - Helix BioPharma is pleased to announce that its wholly-owned subsidiary, PharmaDerm Laboratories, has entered into an agreement with Apotex, the largest Canadian-owned pharmaceutical company, to identify and characterize a lead formulation for Apotex's burgeoning topical therapeutic product line.